医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK1593 医美概念股

已收盘 10-22 16:00:00

802.955

-26.188

-3.16%

最高834.120	最低794.353	成交量8,626万
今开833.334	昨收829.144	日振幅4.80%
总市值0.00	流通市值0.00	总股本0.00
成交额5.62亿	换手率--	流通股本0.00
市净率1.11105	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":802.9551,"timestamp":1792656513708,"preClose":829.14355,"halted":0,"volume":86264154,"delay":0,"changeRate":-0.031585,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-26.188477,"latestTime":"10-22 16:00:00","open":833.33356,"high":834.1204,"low":794.3527,"amount":561735957,"amplitude":0.047962,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792719000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1792632600000,1792641600000],[1792645200000,1792656000000]],"pbRate":1.11105,"peRate":10.148077,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK1593","defaultTab":"news","newsList":[{"id":"2677737196","title":"复锐医疗科技(01696)10月21日斥资28.05万港元回购15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677737196","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677737196?lang=zh_cn&edition=full","pubTime":"2026-10-21 19:17","pubTimestamp":1792581457,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复锐医疗科技(01696)发布公告，于2026年10月21日斥资28.05万港元回购15万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1593","01696","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677624441","title":"贝莱德在复星医药的H股好仓比例上升0.77%至6.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677624441","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677624441?lang=zh_cn&edition=full","pubTime":"2026-10-21 17:21","pubTimestamp":1792574477,"startTime":"0","endTime":"0","summary":"南财智讯10月21日电，香港交易所披露信息显示，BlackRock,Inc.（贝莱德）在复星医药的H股好仓（L）比例于10月16日从5.99%上升至6.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610213902716433.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610213902716433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0060","BK0175","BK1191","BK0183","600196","BK0196","BK0239","BK1515","BK0028","BK0187","BK0096","BK1593","02196","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676693234","title":"丽丰控股(01125.HK)公布年度业绩 拥有人应占净亏损约5.92亿港元 同比增长41.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676693234","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676693234?lang=zh_cn&edition=full","pubTime":"2026-10-20 20:16","pubTimestamp":1792498619,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1240","BK1593","01125"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676662354","title":"复锐医疗科技(01696.HK)10月20日耗资约18.31万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676662354","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676662354?lang=zh_cn&edition=full","pubTime":"2026-10-20 18:27","pubTimestamp":1792492036,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1585","BK1593","01696","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676669466","title":"贝莱德在复星医药的H股好仓比例上升0.29%至6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676669466","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676669466?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:21","pubTimestamp":1792488060,"startTime":"0","endTime":"0","summary":"南财智讯10月20日电，香港交易所披露信息显示，BlackRock,Inc.（贝莱德）在复星医药的H股好仓（L）比例于10月14日从5.99%上升至6.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610203901385187.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610203901385187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","BK1593","BK0096","BK0012","BK1515","BK0239","BK1191","BK0183","BK0187","BK0196","600196","BK0060","BK0028","BK0175","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676666035","title":"复星医药：公司坚持对资金、负债及其风险的管控","url":"https://stock-news.laohu8.com/highlight/detail?id=2676666035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676666035?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:09","pubTimestamp":1792487356,"startTime":"0","endTime":"0","summary":"证券之星消息，复星医药10月20日在投资者关系平台上答复投资者关心的问题。截至目前，公司存量担保均发生于公司与控股子公司之间、或控股子公司之间，担保所涉融资系为满足相关控股子公司实际经营之需要，风险相对可控。公司坚持对资金、负债及其风险的管控，近年来持续优化融资结构、控制融资成本，并审慎开展担保，以期保持合理负债水平，持续推动公司稳健经营和可持续发展。感谢您对公司的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000025560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK1191","BK1593","BK0060","BK0096","BK0196","BK0175","BK0188","600196","BK1515","02196","BK0187","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676660396","title":"复星医药：公司自身将持续聚焦创新药放量、药械新品上市、海外业务拓展及经营效率提升等重点工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2676660396","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676660396?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:09","pubTimestamp":1792487355,"startTime":"0","endTime":"0","summary":"证券之星消息，复星医药10月20日在投资者关系平台上答复投资者关心的问题。二级市场股价短期分时波动受市场整体环境、投资者交易行为、资金流向及市场情绪等多重因素影响，具有较强的市场交易属性。公司业务覆盖制药、医疗器械与医学诊断、医疗健康服务等领域。公司自身将持续聚焦创新药放量、药械新品上市、海外业务拓展及经营效率提升等重点工作，以持续改善经营表现，为公司长期价值提供支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000025558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","06978","BK0183","BK1515","02196","BK0175","BK0196","600196","BK0012","BK0028","BK0239","BK0188","BK1593","159992","BK1574","BK0187","BK1161","BK0060","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676340666","title":"四环医药（00460）两款产品相继于香港获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2676340666","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676340666?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:59","pubTimestamp":1792486780,"startTime":"0","endTime":"0","summary":"金吾财讯 | 四环医药（00460）公告公布，近期，集团旗下渼颜空间生物科技（吉林）有限公司（“渼颜空间”）自主研发及生产的注射用聚己内酯微球面部填充剂（“PCL”）、注射用透明质酸钠复合溶液(FL)（“动能素”），已相继于香港获批上市。此次获批的注射用聚己内酯微球面部填充剂获批规格包括0.5mL╱支、1.0mL╱支、2.0mL╱支；注射用透明质酸钠复合溶液获批规格包括0.5mL╱支、1.0mL╱支、1.5mL╱支、2.0mL╱支、2.5mL╱支、3.0mL╱支、5mL╱盒（内含2支2.5mL╱支规格产品）。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/MGVkMTYyODU4OTM2NDU2Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MGVkMTYyODU4OTM2NDU2Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","00460","BK1191","IPOS","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676666843","title":"四环医药(00460.HK)：渼颜空间自主研发的注射用聚己内酯微球面部填充剂、注射用透明质酸钠复合溶液在香港获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2676666843","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676666843?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:54","pubTimestamp":1792486454,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00460","BK1600","BK1191","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675789518","title":"复星医药（600196）披露为控股子公司提供担保的进展公告，10月16日股价下跌0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675789518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675789518?lang=zh_cn&edition=full","pubTime":"2026-10-16 22:53","pubTimestamp":1792162390,"startTime":"0","endTime":"0","summary":"近日，上海复星医药（集团）股份有限公司发布《关于为控股子公司提供担保的进展公告》。公告显示，公司为多家控股子公司提供担保，涉及复星健康、复星雅立峰、健嘉东麟、蚌埠健嘉、武汉健嘉、成都健嘉和北京健嘉，担保金额合计人民币48,257.32万元。截至2026年10月16日，本集团实际对外担保余额折合人民币约1,831,534万元，占2025年末经审计净资产的37.58%，无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600040852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK1593","BK0175","BK1515","BK0183","BK0028","02196","BK0239","BK0060","600196","BK0012","BK0096","BK0188","BK1191","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675594812","title":"The Goldman Sachs Group, Inc.增持时代天使(06699.HK)1.72万股 每股作价约81.85港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675594812","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675594812?lang=zh_cn&edition=full","pubTime":"2026-10-16 19:55","pubTimestamp":1792151711,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06699","BK1593","BK1587","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675857565","title":"复锐医疗科技(01696.HK)10月15日斥资18.1万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675857565","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675857565?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:40","pubTimestamp":1792060848,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1585","01696","BK1593","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675961573","title":"四环医药抢先押注“全长三螺旋”，一场重组人III型胶原蛋白稀缺原料的卡位战","url":"https://stock-news.laohu8.com/highlight/detail?id=2675961573","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675961573?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:51","pubTimestamp":1791939099,"startTime":"0","endTime":"0","summary":"提前锁定了一张下一轮竞争的门票。","market":"fut","thumbnail":"https://img7.gelonghui.com/column/10.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/10.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6975430","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["00460","BK1515","BK1593","BK1600","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675351391","title":"复锐医疗科技(01696)10月13日斥资15.7万港元回购7.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675351391","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675351391?lang=zh_cn&edition=full","pubTime":"2026-10-13 19:59","pubTimestamp":1791892766,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复锐医疗科技(01696)发布公告，于2026年10月13日斥资15.7万港元回购7.92万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","BK1593","01696","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675583353","title":"三生制药(01530)10月13日斥资1165万港元回购80万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675583353","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675583353?lang=zh_cn&edition=full","pubTime":"2026-10-13 18:18","pubTimestamp":1791886687,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药(01530)发布公告，于2026年10月13日，该公司斥资1165万港元回购80万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261013/32395438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1593","BK1161","HK0000165453.HKD","BK1583","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674580571","title":"复星医药（600196）披露第三季度业绩审议安排，10月12日股价下跌0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674580571","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674580571?lang=zh_cn&edition=full","pubTime":"2026-10-12 22:53","pubTimestamp":1791816795,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，复星医药报收于23.66元，较前一交易日下跌0.96%，最新总市值为631.82亿元。该股当日开盘23.93元，最高24.1元，最低23.62元，成交额达4.24亿元，换手率为0.84%。近日，复星医药发布H股公告，披露公司董事会谨定于2026年10月27日举行会议，考虑及通过本公司及其附属公司截至2026年9月30日止九个月的第三季度业绩并予以刊发。公告日期为2026年10月12日，并列出了当前董事会成员名单。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200035791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0183","BK0239","BK1191","BK1593","BK0196","02196","BK0175","BK0012","BK0060","BK0187","BK1515","BK0028","BK0096","600196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674872680","title":"复锐医疗科技(01696)10月12日斥资19.82万港元回购9.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674872680","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674872680?lang=zh_cn&edition=full","pubTime":"2026-10-12 19:33","pubTimestamp":1791804823,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复锐医疗科技(01696)发布公告，于2026年10月12日，该公司斥资19.82万港元回购9.92万股股份，每股回购价1.98-2港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506087.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01696","BK1100","BK1585","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674501872","title":"复锐医疗科技(01696.HK)10月12日斥资19.82万港元回购9.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674501872","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674501872?lang=zh_cn&edition=full","pubTime":"2026-10-12 19:33","pubTimestamp":1791804823,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","BK1585","01696","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674592879","title":"三生制药(01530.HK)10月12日斥资1480万港元回购100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674592879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674592879?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:11","pubTimestamp":1791799891,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HK0000165453.HKD","BK1593","01530","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674875816","title":"丽丰控股(01125)发盈警 预期年度股东应占综合亏损同比增加不少于40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674875816","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674875816?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:26","pubTimestamp":1791797180,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽丰控股(01125)发布公告，预期本年度的本公司拥有人应占综合亏损将较截至2025年7月31日止年度的亏损约4.19亿港元增加不少于40%。亏损增加的主要原因为本年度因出售横琴创新方第二期的一幢住房大楼及撇减横琴创新方第二期的物业而产生亏损。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"丽丰控股(01125)发盈警 预期年度股东应占综合亏损同比增加不少于40%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1240","01125"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0272},{"period":"1month","weight":-0.0555},{"period":"3month","weight":-0.0618},{"period":"6month","weight":-0.0895},{"period":"1year","weight":-0.0913},{"period":"ytd","weight":-0.0772}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1593","nameEN":"BK1593"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医美概念股,BK1593,医美概念股股票,医美概念股股票老虎,医美概念股股票老虎国际,医美概念股行情,医美概念股股票行情,医美概念股股价,医美概念股股市,医美概念股股票价格,医美概念股股票交易,医美概念股股票购买,医美概念股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}